ES2073735T3 - Nuevos analogos de la cadena b del factor de crecimiento derivado de plaquetas y metodo para su produccion homogenea. - Google Patents
Nuevos analogos de la cadena b del factor de crecimiento derivado de plaquetas y metodo para su produccion homogenea.Info
- Publication number
- ES2073735T3 ES2073735T3 ES91902366T ES91902366T ES2073735T3 ES 2073735 T3 ES2073735 T3 ES 2073735T3 ES 91902366 T ES91902366 T ES 91902366T ES 91902366 T ES91902366 T ES 91902366T ES 2073735 T3 ES2073735 T3 ES 2073735T3
- Authority
- ES
- Spain
- Prior art keywords
- analogs
- pdgf
- present
- growth factor
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
SE PRESENTAN NUEVOS ANALOGOS PLATELED-DERIVADOS DEL FACTOR DEL CRECIMIENTO (PDFG), CONFORME A LA PRESENTE INVENCION. ASIMISMO SE PRESENTA UN METODO PARA LA PRODUCCION DE CANTIDADES HOMOGENEAS DE ESTOS NOVISIMOS ANALOGOS. LOS NUEVOS ANALOGOS DE LA PRESENTE INVENCION, CUANDO ESTAN REPLEGADOS, CONTIENEN SUBSTANCIALMENTE LA MISMA ACTIVIDAD BIOLOGICA QUE EN ESTADO NATURAL PDGF B SUB 109. EL METODO DE LA PRESENTE INVENCION EMPLEA EL USO DE UN CORDON DE BLOQUEO EN EL GENE C-SIS, U OTRA SECUENCIA CODIFICADA POR UNA PROTEINA PRECURSORA DE PDGF B SUB 109 O ANALOGOS EN UNA POSICION QUE CORRESPONDE CASI A UN AMINOACIDO 111, A CASI UN AMINOACIDO 160. EL METODO DE LA PRESENTE INVENCION, DA POR RESULTADO LA PRODUCCION DE CANTIDADES HOMOGENEAS RELATIVAMENTE AMPLIAS DE RECOMBINANTES PDGF B DESDE CELULAS PATRONES DE ELEVADA EXPRESION, COMO EL "COLI E".
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/454,794 US5149792A (en) | 1989-12-19 | 1989-12-19 | Platelet-derived growth factor B chain analogs |
| US07/624,451 US5272064A (en) | 1989-12-19 | 1990-12-13 | DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2073735T3 true ES2073735T3 (es) | 1995-08-16 |
Family
ID=27037609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91902366T Expired - Lifetime ES2073735T3 (es) | 1989-12-19 | 1990-12-17 | Nuevos analogos de la cadena b del factor de crecimiento derivado de plaquetas y metodo para su produccion homogenea. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5272064A (es) |
| EP (1) | EP0458959B1 (es) |
| JP (1) | JPH04504064A (es) |
| AT (1) | ATE123949T1 (es) |
| AU (1) | AU646014B2 (es) |
| CA (1) | CA2032675A1 (es) |
| DE (1) | DE69020335T2 (es) |
| DK (1) | DK0458959T3 (es) |
| ES (1) | ES2073735T3 (es) |
| FI (1) | FI913892A0 (es) |
| GR (1) | GR3017317T3 (es) |
| IE (1) | IE904608A1 (es) |
| IL (1) | IL96723A0 (es) |
| NO (1) | NO913232D0 (es) |
| NZ (1) | NZ236549A (es) |
| PT (1) | PT96272A (es) |
| WO (1) | WO1991008761A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993016719A2 (en) * | 1992-02-26 | 1993-09-02 | Allergan, Inc. | Use of platelet derived growth factor in ophthalmic wound healing |
| IL105176A0 (en) * | 1992-03-30 | 1993-07-08 | Schering Corp | Monomeric platelet-derived growth factor and prevention of stenosis or restenosis |
| JP2005521401A (ja) | 2002-03-27 | 2005-07-21 | イミュネックス・コーポレーション | ポリペプチド産生を増加させる方法 |
| AU2004209668A1 (en) * | 2003-02-04 | 2004-08-19 | Flanders Interuniversity Institute For Biotechnology | VEGF-B and PDGF modulation of stem cells |
| EP2454368A4 (en) | 2009-07-17 | 2013-01-09 | Aaron Thomas Tabor | COMPOSITIONS AND METHOD FOR THE GENETIC MODIFICATION OF COSMETIC FUNCTION CELLS FOR IMPROVING THE COSMETIC APPEARANCE PICTURE |
| SG187198A1 (en) | 2010-08-05 | 2013-03-28 | Amgen Inc | Dipeptides to enhance yield and viability from cell cultures |
| SI2699293T1 (sl) | 2011-04-20 | 2019-05-31 | Amgen Inc. | Avtoinjekcijski aparat |
| US9133493B2 (en) | 2011-04-21 | 2015-09-15 | Amgen Inc. | Method for culturing mammalian cells to improve recombinant protein production |
| CA2838695C (en) | 2011-07-01 | 2017-02-14 | Amgen Inc. | Mammalian cell culture |
| CA2840637A1 (en) | 2011-09-02 | 2013-03-07 | Amgen Inc. | Pharmaceutical product and method of analysing light exposure of a pharmaceutical product |
| AR089231A1 (es) | 2011-12-15 | 2014-08-06 | Amgen Inc | Metodo de floculacion |
| WO2014109858A1 (en) | 2013-01-14 | 2014-07-17 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| EP3395423B1 (en) | 2013-03-14 | 2023-09-20 | Amgen Inc. | Removal of leaked affinity purification ligand |
| TWI832345B (zh) | 2013-03-14 | 2024-02-11 | 美商安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
| EP2968760B1 (en) | 2013-03-15 | 2024-01-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
| TWI639453B (zh) | 2013-03-15 | 2018-11-01 | 美商安美基公司 | 用於注射器之匣盒 |
| US9481901B2 (en) | 2013-05-30 | 2016-11-01 | Amgen Inc. | Methods for increasing mannose content of recombinant proteins |
| CA2929077C (en) | 2013-10-31 | 2024-05-28 | Amgen Inc. | Use of monensin to regulate glycosylation of recombinant proteins |
| WO2015105609A1 (en) | 2014-01-13 | 2015-07-16 | Amgen Inc. | Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins |
| US10106829B2 (en) | 2014-01-29 | 2018-10-23 | Amgen Inc. | Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins |
| IL282517B (en) | 2014-01-29 | 2022-07-01 | Amgen Inc | Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins |
| HUE042277T2 (hu) | 2014-06-04 | 2019-06-28 | Amgen Inc | Eljárások fehérjék begyûjtésére emlõssejttenyészetekbõl |
| ES2962593T3 (es) | 2014-11-19 | 2024-03-20 | Amgen Inc | Cuantificación de resto glucano en glucoproteínas recombinantes |
| PL3227454T3 (pl) | 2014-12-01 | 2020-07-27 | Amgen Inc. | Sposób manipulowania poziomem zawartości glikanów w glikoproteinie |
| AU2018368338A1 (en) | 2017-11-16 | 2020-04-09 | Amgen Inc. | Autoinjector with stall and end point detection |
| WO2023079058A1 (en) | 2021-11-05 | 2023-05-11 | Yokogawa Insilico Biotechnology Gmbh | Cell culture with reduced production of lactate |
| AU2022424002A1 (en) | 2021-12-29 | 2024-06-13 | Bristol-Myers Squibb Company | Generation of landing pad cell lines |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4479896A (en) * | 1981-12-11 | 1984-10-30 | Antoniades Harry N | Method for extraction localization and direct recovery of platelet derived growth factor |
| US4766073A (en) * | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
| US4769328A (en) * | 1984-10-12 | 1988-09-06 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in yeast |
| US4801542A (en) * | 1984-10-12 | 1989-01-31 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
| EP0487116B1 (en) * | 1984-10-12 | 1999-12-29 | ZymoGenetics, Inc. | Biologically active PDGF analogs in eucaryotic cells |
| EP0259632B1 (en) * | 1986-08-13 | 1995-12-13 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
| DE3834079A1 (de) * | 1988-10-06 | 1990-04-12 | Biotechnolog Forschung Gmbh | Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren |
| IL96682A0 (en) * | 1989-12-15 | 1991-09-16 | Amgen Inc | Production of biologically active platelet-derived growth factor from high expression host cell systems |
-
1990
- 1990-12-13 US US07/624,451 patent/US5272064A/en not_active Expired - Lifetime
- 1990-12-17 DK DK91902366.3T patent/DK0458959T3/da active
- 1990-12-17 WO PCT/US1990/007451 patent/WO1991008761A1/en active IP Right Grant
- 1990-12-17 EP EP91902366A patent/EP0458959B1/en not_active Expired - Lifetime
- 1990-12-17 AT AT91902366T patent/ATE123949T1/de not_active IP Right Cessation
- 1990-12-17 AU AU71534/91A patent/AU646014B2/en not_active Ceased
- 1990-12-17 JP JP3502837A patent/JPH04504064A/ja active Pending
- 1990-12-17 DE DE69020335T patent/DE69020335T2/de not_active Expired - Fee Related
- 1990-12-17 ES ES91902366T patent/ES2073735T3/es not_active Expired - Lifetime
- 1990-12-19 IL IL96723A patent/IL96723A0/xx unknown
- 1990-12-19 PT PT96272A patent/PT96272A/pt not_active Application Discontinuation
- 1990-12-19 NZ NZ236549A patent/NZ236549A/xx unknown
- 1990-12-19 CA CA002032675A patent/CA2032675A1/en not_active Abandoned
- 1990-12-19 IE IE460890A patent/IE904608A1/en unknown
-
1991
- 1991-08-16 FI FI913892A patent/FI913892A0/fi not_active Application Discontinuation
- 1991-08-19 NO NO913232A patent/NO913232D0/no unknown
-
1995
- 1995-09-06 GR GR950402446T patent/GR3017317T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0458959A1 (en) | 1991-12-04 |
| IL96723A0 (en) | 1991-09-16 |
| JPH04504064A (ja) | 1992-07-23 |
| AU7153491A (en) | 1991-07-18 |
| US5272064A (en) | 1993-12-21 |
| GR3017317T3 (en) | 1995-12-31 |
| IE904608A1 (en) | 1991-06-19 |
| DK0458959T3 (da) | 1995-08-14 |
| PT96272A (pt) | 1991-09-30 |
| CA2032675A1 (en) | 1991-06-20 |
| DE69020335D1 (de) | 1995-07-27 |
| FI913892A0 (fi) | 1991-08-16 |
| WO1991008761A1 (en) | 1991-06-27 |
| EP0458959A4 (en) | 1993-06-16 |
| NO913232L (no) | 1991-08-19 |
| NZ236549A (en) | 1993-03-26 |
| ATE123949T1 (de) | 1995-07-15 |
| EP0458959B1 (en) | 1995-06-21 |
| DE69020335T2 (de) | 1995-11-02 |
| NO913232D0 (no) | 1991-08-19 |
| AU646014B2 (en) | 1994-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2073735T3 (es) | Nuevos analogos de la cadena b del factor de crecimiento derivado de plaquetas y metodo para su produccion homogenea. | |
| LU90408I2 (fr) | Regranex-becaplermin | |
| SE8105657L (sv) | Mikrobiell framstellning av humanfibroblastinterferon | |
| ATE125869T1 (de) | Wachstumshormonfusionsproteine. | |
| MY102472A (en) | Preparation of funtional human urokinase proteins. | |
| DE3584579D1 (de) | Herstellung von polypeptiden mit human-gammainterferon-aktivitaet. | |
| ATE145241T1 (de) | Polypeptid, das zur interaktion mit thrombin fähig ist | |
| PT100651A (pt) | Muteinas da interleucina 6 (il-6) isentas de cisteina | |
| KR900702027A (ko) | 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체 | |
| KR880701073A (ko) | 제조합 dna 기법에 의해 생성된 민악티빈 | |
| ATE145939T1 (de) | Mitogen für die glatte muskulatur und dessen kodierende dns | |
| Proost et al. | Purification, sequence analysis, and biological characterization of a second bovine monocyte chemotactic protein-1 (Bo MCP-1B) | |
| JPS6437291A (en) | Human cytochrome c gene and use thereof | |
| ATE241698T1 (de) | Hst-2 mutein, dafür kodierende dns und herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 458959 Country of ref document: ES |